about
Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineagesDifferential modulation of cell cycle progression distinguishes members of the myogenic regulatory factor family of transcription factorsUTX mediates demethylation of H3K27me3 at muscle-specific genes during myogenesisComparative expression profiling identifies differential roles for Myogenin and p38α MAPK signaling in myogenesisConstitutive heterochromatin reorganization during somatic cell reprogrammingPax7 activates myogenic genes by recruitment of a histone methyltransferase complex.Polycomb repressive complex 1 provides a molecular explanation for repeat copy number dependency in FSHD muscular dystrophy.Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription.A KAP1 phosphorylation switch controls MyoD function during skeletal muscle differentiation.Nuclear matrix-associated protein SMAR1 regulates alternative splicing via HDAC6-mediated deacetylation of Sam68.Activator-mediated recruitment of the MLL2 methyltransferase complex to the beta-globin locus.Reprogramming progeria fibroblasts re-establishes a normal epigenetic landscape.UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemiaUTX demethylase activity is required for satellite cell-mediated muscle regeneration.MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state.Ligand-dependent activation of transcription in vitro by retinoic acid receptor alpha/retinoid X receptor alpha heterodimers that mimics transactivation by retinoids in vivoIn vitro transcription system delineates the distinct roles of the coactivators pCAF and p300 during MyoD/E47-dependent transactivation.Epigenetic regulation of satellite cell activation during muscle regeneration.The origin and fate of muscle satellite cells.Chromatin-wide and transcriptome profiling integration uncovers p38α MAPK as a global regulator of skeletal muscle differentiationA MyoD-generated feed-forward circuit temporally patterns gene expression during skeletal muscle differentiation.Rbfox proteins regulate tissue-specific alternative splicing of Mef2D required for muscle differentiation.Dystrophic muscle environment induces changes in cell plasticity.Teashirt-3, a novel regulator of muscle differentiation, associates with BRG1-associated factor 57 (BAF57) to inhibit myogenin gene expressionTurning on myogenin in muscle: a paradigm for understanding mechanisms of tissue-specific gene expression.Activating transcription factor 3 promotes loss of the acinar cell phenotype in response to cerulein-induced pancreatitis in mice.Identification of the retinoic acid-inducible all-trans-retinoic acid 4-hydroxylase.GSK3 temporally regulates neurogenin 2 proneural activity in the neocortex.Splicing of Ezh1 gets muscle out of stressful situations.Analysis of epigenetic modifications of chromatin at specific gene loci by native chromatin immunoprecipitation of nucleosomes isolated using hydroxyapatite chromatography.Trichostatin A enhances vascular repair by injected human endothelial progenitors through increasing the expression of TAL1-dependent genes.Diversification of the muscle proteome through alternative splicing.A chemical toolbox for the study of bromodomains and epigenetic signalingIncreased biological activity of 20-epi-1,25-dihydroxyvitamin D3 is due to reduced catabolism and altered protein bindingMetabolism of the vitamin D analog EB1089 by cultured human cells: redirection of hydroxylation site to distal carbons of the side-chainRedirecting traffic in the nucleusCompacting Chromatin to Ensure Muscle Satellite Cell QuiescenceThe exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance
P50
Q24319742-BE928906-4D10-4C77-BDF2-2320A11737F4Q27022808-4CA52DA4-9784-4CC9-94F9-E0F24FE87591Q28587655-98A71BDF-8AD3-4E99-9119-4FB7A234635FQ29347275-FEC4A70B-D2E4-4291-A554-4A62AE821FE2Q30500491-05F96128-BEC9-4B16-9C83-A9729962E54DQ33309162-597E270A-388C-4C05-9522-56596628A8F6Q33614782-95E7A747-73C1-44B3-8DD4-2B98AE9CEB3AQ34290262-A2CD4335-FD2D-42D0-8FE9-830E9BAE0F60Q34465548-9EDF35F3-7921-4DA9-BB39-5EF406A4F6D3Q35818741-390FD5AC-2715-4423-8929-4247713C0B3DQ36082540-8E9FDC25-1A9B-4F11-B445-7F23C3836936Q36396535-0EE50491-E10A-4C49-AB35-E97A96CEE760Q36661533-F4F979C9-CB8D-46E7-84DA-6FF2B4C282C0Q36737973-5040F599-5DD2-44F7-BEAE-B39DF1464A08Q37141809-86797B62-2893-4F92-A6C2-5852968616EAQ37167696-9BCEDABE-5C4B-41B9-AE06-F7E9DC62B798Q37415625-F0336A78-AA98-4067-981D-DE764ABB3F3EQ37872042-2F154AAF-4D42-4B95-BBA0-82D2F5D42E23Q37978773-13687910-0536-4A03-B286-FE5C8E146DE8Q38293191-5D97BABF-AEFD-41A3-A7D1-024F71E99094Q38335789-875B8A98-A2E0-4349-9178-8DD20B0DF61FQ38917710-D071EE27-17F0-4201-935F-4ADCA9E1BE81Q39027193-523C7EDD-436B-4A16-AB3C-14C420E64A52Q39548075-660604CF-40B0-4343-B266-D594FD5FF283Q42234367-AC34C5F9-FCD7-45C7-96D0-D3C29DE94B5BQ43491732-39B77CB5-9EBC-49A8-8A2C-7BDE31865757Q47073891-0D791ACD-B47D-4E08-9992-EC8DFDE8F9BCQ48481509-0385423C-6626-4349-B8CC-06C7D24956FDQ51020757-C185F8B4-CA39-4068-9BEE-0801FF9D3E4BQ51574817-6E37C667-3425-4282-9810-630889368292Q51738076-4A9F0942-9666-4A1A-AE88-FC03E3291B72Q52671372-C5F89A12-C001-44F9-B9E1-1ACF10E02965Q64097709-55ADE00F-14F6-4E87-9448-E79CB458B6A1Q72340165-C022B387-79B1-40DE-BB9A-F4E77FE98EA8Q73253213-94E162B7-46B9-4F26-B11B-6E1192B7943CQ84948018-8FC791C5-BB1D-432C-920D-8AE41951354BQ87236383-A6250321-684C-419A-873B-359DDF0D98BCQ91174411-BB38E676-3AB4-4EB4-A32B-0536B8E8A4D7
P50
description
researcher
@en
name
F J Dilworth
@en
F J Dilworth
@nl
type
label
F J Dilworth
@en
F J Dilworth
@nl
prefLabel
F J Dilworth
@en
F J Dilworth
@nl
P106
P31
P496
0000-0002-6265-8102